Company Filing History:
Years Active: 1992-2009
Title: The Innovative Contributions of Yoshiki Makabe
Introduction
Yoshiki Makabe is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of thermoplastic resin technology, holding a total of 8 patents. His work focuses on the development of innovative materials and processes that enhance the properties and applications of thermoplastic resins.
Latest Patents
Among his latest patents is a groundbreaking invention related to tablets made from thermoplastic resin and filler. This patent describes a process for producing tablets where the compositional ratio of thermoplastic resin and filler is meticulously controlled. The thermoplastic resin constitutes between 1 to 40% by volume, while the filler makes up 60 to 99% by volume. This innovative method involves either compression-molding thermoplastic resin powder and filler into tablets or melt-kneading the two components before compression-molding. The high filler content is unprecedented in the field, allowing the tablets to efficiently exhibit the properties of the filler.
Career Highlights
Yoshiki Makabe is currently associated with Toray Industries, Inc., a leading company in advanced materials. His work at Toray has positioned him as a key player in the development of new materials that meet the evolving demands of various industries. His innovative approaches have not only advanced the technology but have also contributed to the company's reputation for excellence in material science.
Collaborations
Throughout his career, Yoshiki has collaborated with notable colleagues, including Hideyuki Umetsu and Toshihide Inoue. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Yoshiki Makabe's contributions to the field of thermoplastic resin technology are noteworthy and impactful. His innovative patents and collaborative efforts continue to shape the future of material science.